Latest Market Segmentation News

Cash Converters International Limited reports a robust 41% increase in statutory net profit for FY2025, driven by a strategic transformation that includes exiting payday lending, expanding luxury retail, and growing its franchise footprint in Australia and the UK.

Intelligent Monitoring Group Limited (IMG) reported a 44% revenue surge to $174.9 million in FY25, driven by four key acquisitions and organic growth, while investing heavily in AI-powered video monitoring technology.

Prime Financial Group Ltd reported robust FY25 results, driven by a 21% revenue increase and key acquisitions that expanded its client base and funds under management. The company’s strategic focus on M&A, technology, and mid-market opportunities sets the stage for ambitious future growth.

IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Praemium Limited reported a robust 25% revenue increase and a 55% jump in net profit for FY2025, driven by strategic client wins and innovative product launches.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

EQT Holdings Limited reported record funds under management and a solid financial performance for FY25, successfully completing its three-year strategic integration program. The company’s margin recovery and dividend growth signal a confident outlook amid ongoing regulatory challenges.

FirstWave Cloud Technology is launching its first AI-powered compliance management feature for Open-AudIT, aiming to convert a large base of free users into paying customers through a subscription model integrated with AWS.

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

Sims Limited reported a 4.1% rise in FY25 sales revenue to $7.49 billion and a 198% surge in underlying EBIT, driven by strong metal trading margins and AI-related demand growth. The company also boosted its fully franked dividend by 130%, signaling confidence despite ongoing market headwinds.

Audinate Group Limited reported a 32% revenue decline and a net loss in FY25 amid industry headwinds, while expanding gross margins and completing a strategic acquisition to boost its video capabilities.